A Novel Mass Spectrometry Paradigm to Analyze Classical and New Biotherapeutic Modalities
May 1st 2023A new fragmentation approach—tunable electron-activated dissociation (EAD) tandem mass spectrometry (MS/MS)—offers a solution to better improve the detection and characterization of impurities in lipid nanoparticles and impurities in other biopharmaceutical modalities.